Automated Non-Invasive Blood Pressure Study
1 other identifier
observational
50
1 country
2
Brief Summary
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2025
CompletedStudy Start
First participant enrolled
April 14, 2025
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 27, 2026
August 1, 2026
1.7 years
March 31, 2025
August 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Primary Outcome Measure
The primary outcome is to collect SpO2 data using Automated Non-Invasive Blood Pressure from subjects in ICU, OR and PACU environment using the investigational system. This data will be used for engineering development purposes.
Up to 24 hours after time of enrollment
Other Outcomes (1)
Safety Outcome
24 months
Eligibility Criteria
Patients treated in Meilahti hospital
You may qualify if:
- Able to provide written informed consent or have a LDR to provide written informed consent;
- Are being cared for in OR, PACU or ICU and are expected to remain in the unit for the duration of the study procedure;
- Have an invasive blood pressure measurement as a standard of care; AND
- Are 18 years of age or older.
You may not qualify if:
- Are known to be pregnant;
- Are breastfeeding;
- Are suffering from infection(s) that require isolation; OR
- Have an external heart assistant device.
- PI or caring physician decision due to subject health condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GE Healthcarelead
Study Sites (2)
Helsinki University Hospital
Helsinki, 00290, Finland
Helsinki University Hospital
Helsinki, 00290, Finland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2025
First Posted
August 27, 2026
Study Start
April 14, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share